Crossref
journal-article
Elsevier BV
Journal of the Neurological Sciences (78)
References
77
Referenced
48
10.1016/j.advenzreg.2003.11.012
/ Adv Enzyme Regul / Methylation demand and homocysteine metabolism. by Stead (2004)10.1016/S0166-2236(03)00032-8
/ Trends Neurosci / Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders by Mattson (2003)10.1146/annurev.nutr.19.1.217
/ Annu Rev Nutr / Homocysteine metabolism by Selhub (1999)10.1002/jcp.1041460108
/ J Cell Physiol / Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture by Christensen (1991)10.1042/bj2980415
/ Biochem J / Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism by Miller (1994)10.1007/s002340050119
/ Neuroradiology / Hyperhomocysteinaemia; with reference to its neuroradiological aspects by van den (1995)10.1002/ajmg.1320340320
/ Am J Med Genet / Functional methionine synthase deficiency (cblE and cblG): clinical and biochemical heterogeneity by Watkins (1989)10.1023/A:1018675624181
/ J Thromb Thrombolysis / Homocysteine and risk of cardiovascular disease by Andreotti (2000)10.1016/S0140-6736(05)65956-9
/ Lancet / Serum total homocysteine concentration and risk of stroke by Perry (1996)10.1345/aph.18457
/ Ann Pharmacother / Homocysteine as a risk factor for atherosclerosis by Temple (2000)10.1042/bst022341s
/ Biochem Soc Trans / Homocysteine induced endothelial cell toxicity and its protection by Blundell (1994)10.1016/0021-9150(95)05730-7
/ Atherosclerosis / Homocysteine mediated endothelial cell toxicity and its amelioration by Blundell (1996)10.1097/00007890-200202270-00034
/ Transplantation / Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients by Abdelfatah (2002)10.1172/JCI118776
/ J Clin Invest / The oxidant stress of hyperhomocyst(e)inemia by Loscalzo (1996)10.1002/jcb.1175
/ J Cell Biochem / Aru GM, Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function by Mujumdar (2001)10.1161/01.HYP.0000127914.94292.76
/ Hypertension / Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways by Suhara (2004)10.1096/fj.00-0848com
/ FASEB J / Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to gamma-glutamyl transpeptidase activity by Bessede (2001)10.1074/jbc.M100747200
/ J Biol Chem / Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response by Zhang (2001)10.1523/JNEUROSCI.20-18-06920.2000
/ J Neurosci / Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity by Kruman (2000)10.1016/0167-5699(94)90018-3
/ Immunol Today / Oxidative stress as a mediator of apoptosis by Buttke (1994)10.1080/10715760400017269
/ Free Radic Res / No evidence for oxidative stress as a mechanism of action of hyperhomocysteinemia in humans by Huerta (2004)10.1111/j.1432-1033.2004.04070.x
/ Eur J Biochem / Effects of homocysteine on apoptosis-related proteins and anti-oxidant systems in isolated human lymphocytes by Mangiagalli (2004)10.1093/jn/128.7.1204
/ J Nutr / Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women by Jacob (1998)10.1080/07315724.1998.10718790
/ J Am Coll Nutr / Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis by Siri (1998)10.1038/ng0595-111
/ Nat Genet / A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase by Frosst (1995)10.1089/ars.2005.7.813
/ Antioxid Redox Signal / The role of cystathionine beta-synthase in homocysteine metabolism by Jhee (2005)10.1161/01.CIR.94.12.3074
/ Circulation / Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease by Deloughery (1996)10.1161/01.CIR.94.10.2410
/ Circulation / Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians by Ma (1996)10.1182/asheducation-2003.1.62
/ Hematology (Am Soc Hematol Educ Program) / Update on cobalamin, folate, and homocysteine by Carmel (2003)10.1016/j.pnpbp.2005.06.025
/ Prog Neuropsychopharmacol Biol Psychiatry / The central nervous system in animal models of hyperhomocysteinemia by Troen (2005){'key': '10.1016/j.jns.2007.01.028_bib31', 'first-page': '1894', 'article-title': 'Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats', 'volume': '55', 'author': 'Pogribny', 'year': '1995', 'journal-title': 'Cancer Res'}
/ Cancer Res / Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats by Pogribny (1995){'key': '10.1016/j.jns.2007.01.028_bib32', 'first-page': '2071s', 'article-title': 'Methyl groups in carcinogenesis: effects on DNA methylation and gene expression', 'volume': '52', 'author': 'Wainfan', 'year': '1992', 'journal-title': 'Cancer Res'}
/ Cancer Res / Methyl groups in carcinogenesis: effects on DNA methylation and gene expression by Wainfan (1992){'key': '10.1016/j.jns.2007.01.028_bib33', 'first-page': '471', 'article-title': 'Hyperhomocysteinemia: a new risk factor for degenerative diseases', 'volume': '48', 'author': 'Herrmann', 'year': '2002', 'journal-title': 'Clin Lab'}
/ Clin Lab / Hyperhomocysteinemia: a new risk factor for degenerative diseases by Herrmann (2002)10.1515/znc-1995-9-1017
/ Z Naturforsch [C] / Homocysteine-induced oxidative damage: mechanisms and possible roles in neurodegenerative and atherogenic processes by Schlussel (1995)10.1016/S0163-7258(96)00097-6
/ Pharmacol Ther / The neurotransmitter candidature of sulphur-containing excitatory amino acids in the mammalian central nervous system by Thompson (1996)10.1002/jnr.10416
/ J Neurosci Res / Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage by Ho (2002)10.1523/JNEUROSCI.22-05-01752.2002
/ J Neurosci / Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease by Kruman (2002)10.1073/pnas.94.11.5923
/ Proc Natl Acad Sci U S A / Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor by Lipton (1997)10.1046/j.0022-3042.2001.00676.x
/ J Neurochem / Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease by Duan (2002)10.1007/BF00969090
/ Neurochem Res / The effects of l-dopa on the activity of methionine adenosyltransferase: relevance to l-dopa therapy and tolerance by Benson (1993)10.1097/00002826-199702000-00007
/ Clin Neuropharmacol / Effect of l-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats by Miller (1997)10.1016/S0024-3205(00)00557-9
/ Life Sci / Effects of l-dopa treatment on methylation in mouse brain: implications for the side effects of l-dopa by Liu (2000)10.1097/00002826-199702000-00007
/ Clin Neuropharmacol / Effect of l-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats by Miller (1997){'key': '10.1016/j.jns.2007.01.028_bib44', 'first-page': '527', 'article-title': "Sulfate and cysteine levels in the plasma of patients with Parkinson's disease", 'volume': '16', 'author': 'Allain', 'year': '1995', 'journal-title': 'Neurotoxicology'}
/ Neurotoxicology / Sulfate and cysteine levels in the plasma of patients with Parkinson's disease by Allain (1995)10.1159/000007984
/ Eur Neurol / Elevated plasma levels of homocysteine in Parkinson's disease by Kuhn (1998)10.1001/archneur.60.1.59
/ Arch Neurol / Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease by Rogers (2003)10.1002/mds.20253
/ Mov Disord / Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease by O'suilleabhain (2004)10.1001/archneur.61.6.865
/ Arch Neurol / Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations by O'suilleabhain (2004)10.1111/j.1468-1331.2004.00973.x
/ Eur J Neurol / Hyperhomocysteinemia in l-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration by Lamberti (2005)10.1016/j.parkreldis.2004.07.008
/ Parkinsonism Relat Disord / Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications by Zoccolella (2005)10.1093/clinchem/47.6.1102
/ Clin Chem / Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease by Blandini (2001)10.1016/S0140-6736(99)01660-8
/ Lancet / Nigral endothelial dysfunction, homocysteine, and Parkinson's disease by Muller (1999)10.1016/S0304-3940(01)01972-3
/ Neurosci Lett / Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease by Muller (2001)10.1152/ajprenal.00465.2004
/ Am J Physiol Renal Physiol / Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers. by Fux (2005)10.4088/JCP.v66n1210
/ J Clin Psychiatry / High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia by Lerner (2005)10.1176/appi.ajp.161.9.1705
/ Am J Psychiatry / Folate, homocysteine, and negative symptoms in schizophrenia by Goff (2004)10.1176/appi.ajp.162.7.1387-a
/ Am J Psychiatry / The significance of homocysteine levels in schizophrenia by O’Donnell (2005)10.1176/appi.ajp.162.7.1388
/ Am J Psychiatry / Letter to the editor by Goff (2005)10.1002/ana.20509
/ Ann Neurol / Methylenetetrahydrofolate reductase C677T genotype and PD by de Lau (2005)10.1007/s00702-002-0758-8
/ J Neural Transm / Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease by Widner (2002)10.1016/j.amjmed.2005.01.052
/ Am J Med / Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease by Sato (2005)10.1016/0009-8981(73)90429-4
/ Clin Chim Acta / The reaction of homocysteine with aldehyde: an explanation of the collagen defects in homocystinuria by Jackson (1973)10.1212/01.wnl.0000183063.99107.5c
/ Neurology / Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease by Irizarry (2005)10.1074/jbc.M112372200
/ J Biol Chem / Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein by Sai (2002)10.1016/S0014-5793(03)00277-1
/ FEBS Lett / Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? by Scarpa (2003)10.1093/ajcn/82.3.627
/ Am J Clin Nutr / High homocysteine and low B vitamins predict cognitive decline in aging men; the Veterans Affairs Normative Aging Study by Tucker (2005)10.1016/j.amjmed.2004.08.019
/ Am J Med / Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging by Kado (2005)10.1093/ajcn/82.4.866
/ Am J Clin Nutr / Homocysteine, vitamin B12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study by Mooijaart (2005)10.1002/mds.20667
/ Mov Disord / Homocysteine and serum markers if immune activation in primary dystonia by Muller (2005)10.1254/jphs.CRJ05003X
/ J Pharmacol Sci / The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins by Hamed (2005)10.1016/j.seizure.2005.11.002
/ Seizure / Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6 by Sener (2006)10.1093/ajcn/82.6.1320
/ Am J Clin Nutr / Westendorp Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease by Stott (2005)10.1016/j.archger.2005.10.002
/ Arch Gerontol Geriatr / Effects of folic acid supplementation on psychomotor performance and hemorheology in healthy elderly subjects by Pathansali (2006)10.1212/01.WNL.0000158476.74580.A8
/ Neurology / Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment by Boxer (2005)10.1212/01.WNL.0000137886.74175.5A
/ Neurology / Homocysteine and l-Dopa: should Parkinson disease patients receive preventive therapy? by Postuma (2004)10.1093/aje/kwh213
/ Am J Epidemiol / Folate intake and risk of Parkinson's disease by Chen (2004)10.1111/j.1365-277X.2004.00532.x
/ J Hum Nutr Diet / A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly by Ellinson (2004)
Dates
Type | When |
---|---|
Created | 18 years, 6 months ago (March 2, 2007, 12:46 p.m.) |
Deposited | 5 years, 4 months ago (April 20, 2020, 5:10 a.m.) |
Indexed | 2 months ago (June 30, 2025, 12:25 p.m.) |
Issued | 18 years, 3 months ago (June 1, 2007) |
Published | 18 years, 3 months ago (June 1, 2007) |
Published Print | 18 years, 3 months ago (June 1, 2007) |
@article{Martignoni_2007, title={Homocysteine and Parkinson’s disease: A dangerous liaison?}, volume={257}, ISSN={0022-510X}, url={http://dx.doi.org/10.1016/j.jns.2007.01.028}, DOI={10.1016/j.jns.2007.01.028}, number={1–2}, journal={Journal of the Neurological Sciences}, publisher={Elsevier BV}, author={Martignoni, E. and Tassorelli, C. and Nappi, G. and Zangaglia, R. and Pacchetti, C. and Blandini, F.}, year={2007}, month=jun, pages={31–37} }